gadolinium dtpa has been researched along with chitosan in 17 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (chitosan) | Trials (chitosan) | Recent Studies (post-2010) (chitosan) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 27,648 | 232 | 21,257 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Block, LH; Fukumori, Y; Ichikawa, H; Tokumitsu, H | 1 |
| Fukumori, Y; Ichikawa, H; Tokumitsu, H | 1 |
| Fukumori, Y; Hiratsuka, J; Ichikawa, H; Kobayashi, T; Sakurai, Y; Tokumitsu, H | 1 |
| Fukumori, Y; Ichikawa, H; Shikata, F; Tokumitsu, H | 1 |
| Fukumori, Y; Ichikawa, H; Saha, TK | 1 |
| Tan, WB; Zhang, Y | 1 |
| Berkland, C; Bilgen, M; Huang, M; Huang, ZL | 1 |
| Akisue, T; Brown, SC; Fujii, M; Fujimoto, T; Fujita, I; Fukumori, Y; Hara, H; Ichikawa, H; Imabori, M; Kawamitsu, H; Kishimoto, K; Kurosaka, M; Moudgil, BM; Sharma, P; Yamamoto, T | 1 |
| Dai, X; Huang, Y; Wu, J; Zhang, Q; Zhang, X | 1 |
| Cho, MY; Chung, KH; Lim, YT; Poo, H; Sung, MH | 1 |
| Cheng, JJ; Feng, Q; He, DN; Liu, XS; Wu, LM; Xu, JR; Zhou, J; Zhu, J | 1 |
| Cao, B; Guo, Z; Han, X; Huang, Y; Yang, X; Zhang, Q | 1 |
| Huang, XZ; Huang, Y; Li, MZ; Liu, Q; Yu, DJ; Zhang, Q; Zhu, WH | 1 |
| Ahmed, A; Guo, J; Hu, Y; Jiang, X; Zhang, C | 1 |
| Cao, J; Gao, H; Hua, MQ; Huang, Y; Lu, ZR; Zhang, Q; Zhang, XY | 1 |
| Cao, Y; Dong, J; Jiang, B; Liu, M; Lu, B; Pei, R; Tong, X; Zhang, H; Zhang, K; Zheng, H | 1 |
| Bao, L; Shen, R; Wang, C; Yuan, H; Zhao, X | 1 |
17 other study(ies) available for gadolinium dtpa and chitosan
| Article | Year |
|---|---|
Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique.
Topics: Carbohydrate Sequence; Chitin; Chitosan; Contrast Media; Dealkylation; Emulsions; Gadolinium; Gadolinium DTPA; Gamma Rays; Microspheres; Molecular Sequence Data; Neoplasms; Neutron Capture Therapy; Particle Size; Radioisotopes | 1999 |
Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization.
Topics: Animals; Chemistry, Pharmaceutical; Chitin; Chitosan; Contrast Media; Emulsions; Gadolinium DTPA; Injections; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microspheres; Neoplasms; Neutron Capture Therapy; Particle Size; Solutions | 1999 |
Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor.
Topics: Animals; Chitin; Chitosan; Gadolinium DTPA; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Neutron Capture Therapy | 2000 |
In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer.
Topics: Animals; Biocompatible Materials; Chitin; Chitosan; Gadolinium; Gadolinium DTPA; L Cells; Melanoma, Experimental; Mice; Nanotechnology; Neoplasms; Neutron Capture Therapy; Tumor Cells, Cultured | 2002 |
Gadolinium diethylenetriaminopentaacetic acid-loaded chitosan microspheres for gadolinium neutron-capture therapy.
Topics: Antineoplastic Agents; Chitosan; Delayed-Action Preparations; Drug Carriers; Gadolinium DTPA; Microspheres; Neutron Capture Therapy | 2006 |
Multi-functional chitosan nanoparticles encapsulating quantum dots and Gd-DTPA as imaging probes for bio-applications.
Topics: Chitosan; Coated Materials, Biocompatible; Contrast Media; Crystallization; Gadolinium DTPA; Image Enhancement; Macromolecular Substances; Magnetic Resonance Imaging; Materials Testing; Microscopy, Fluorescence; Molecular Conformation; Molecular Probe Techniques; Nanostructures; Nanotechnology; Particle Size; Quantum Dots; Surface Properties | 2007 |
Magnetic resonance imaging of contrast-enhanced polyelectrolyte complexes.
Topics: Cell Survival; Cells, Cultured; Chitosan; Colloids; Contrast Media; Electrolytes; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Nanoparticles; Spectroscopy, Fourier Transform Infrared | 2008 |
Accumulation of MRI contrast agents in malignant fibrous histiocytoma for gadolinium neutron capture therapy.
Topics: Cell Line, Tumor; Chitosan; Contrast Media; Gadolinium; Gadolinium DTPA; Histiocytoma, Malignant Fibrous; Humans; Magnetic Resonance Imaging; Metal Nanoparticles; Neutron Capture Therapy; Phantoms, Imaging | 2009 |
Evaluation of diethylenetriaminepentaacetic acid-manganese(II) complexes modified by narrow molecular weight distribution of chitosan oligosaccharides as potential magnetic resonance imaging contrast agents.
Topics: Animals; Carbon Isotopes; Cattle; Chitosan; Contrast Media; Gadolinium DTPA; Ions; Magnetic Resonance Imaging; Manganese; Molecular Weight; Phantoms, Imaging; Serum Albumin, Bovine; Spectrophotometry, Atomic; Spectroscopy, Fourier Transform Infrared; Time Factors | 2011 |
Electrostatically assembled biocompatible polymer nanoparticles for MR/optical dual-modality imaging nanoprobes.
Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Chitosan; Gadolinium DTPA; Humans; Indoles; Magnetic Resonance Imaging; Mice; Microscopy, Fluorescence; Nanoparticles; Polyglutamic Acid; Polymers; Static Electricity | 2011 |
Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
Topics: Administration, Rectal; Animals; Cell Survival; Chitosan; Colon; Contrast Media; Feasibility Studies; Gadolinium DTPA; HeLa Cells; Humans; Image Enhancement; Intestinal Absorption; Intestinal Mucosa; Magnetic Resonance Imaging; Male; Nanoparticles; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values | 2012 |
Gd complexes of diethylenetriaminepentaacetic acid conjugates of low-molecular-weight chitosan oligosaccharide as a new liver-specific MRI contrast agent.
Topics: Animals; Chitosan; Contrast Media; Drug Carriers; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Molecular Weight; Oligosaccharides; Phantoms, Imaging; Rats; Rats, Sprague-Dawley | 2013 |
[Preparation of and study on magnetic resonance imaging performance of metal porphyrin modified by low molecular weight chitosan].
Topics: Chitosan; Contrast Media; Gadolinium DTPA; Magnetic Resonance Imaging; Metalloporphyrins; Molecular Weight | 2013 |
Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging.
Topics: Acrylic Resins; Animals; Chitosan; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Nanoparticles; Rabbits | 2015 |
Chitosan oligosaccharide based Gd-DTPA complex as a potential bimodal magnetic resonance imaging contrast agent.
Topics: Benzaldehydes; Chitosan; Contrast Media; Feasibility Studies; Gadolinium DTPA; Microscopy, Fluorescence; Multimodal Imaging; Oligosaccharides; Phantoms, Imaging; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Oligoethylenimine-grafted chitosan as enhanced T1 contrast agent for in vivo targeted tumor MRI.
Topics: Animals; Aziridines; Cell Line, Tumor; Chitosan; Contrast Media; Folate Receptors, GPI-Anchored; Folic Acid; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Mice; Mice, Nude; Molecular Probe Techniques; Neoplasms, Experimental; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Chitosan derived glycolipid nanoparticles for magnetic resonance imaging guided photodynamic therapy of cancer.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Chlorophyllides; Disease Models, Animal; Drug Delivery Systems; Female; Gadolinium DTPA; Glycolipids; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Nanoparticles; Photochemotherapy; Porphyrins; Radiation-Sensitizing Agents; Stearic Acids; Tumor Burden | 2020 |